Inc. Pavmed serves as Executive at Lucid Diagnostics Inc., where they oversee executive responsibilities. Since joining the company, Inc. Pavmed has executed 13 insider transactions totaling $8.0M, demonstrating a bullish approach to their equity position. Their most recent transaction on Feb 15, 2024 involved transacting 3,331,747 shares valued at $0.
Inc. Pavmed currently holds 31,302,444 shares of Lucid Diagnostics Inc. (LUCD), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Inc. Pavmed has been a net buyer of LUCD stock. They have purchased $8.0M and sold $0 worth of shares.
Inc. Pavmed's most recent insider trade was on Feb 15, 2024, when they sold 3,331,747 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $1.40 |
| Discretionary |
| Nov 30, 2022 | LUCD | $2.7M | Other | 1,479,326 | $1.84 | Discretionary |
| Nov 30, 2022 | LUCD | $549.8K | Other | 331,210 | $1.66 | Discretionary |
| Nov 30, 2022 | LUCD | $550.4K | Other | 221,952 | $2.48 | Discretionary |
| Nov 30, 2022 | LUCD | $2.1M | Other | 1,145,086 | $1.84 | Discretionary |
| Nov 30, 2022 | LUCD | $549.5K | Other | 197,656 | $2.78 | Discretionary |
| Nov 30, 2022 | LUCD | $550.4K | Other | 221,952 | $2.48 | Discretionary |
| Nov 30, 2022 | LUCD | $549.8K | Other | 331,210 | $1.66 | Discretionary |
| Nov 30, 2022 | LUCD | $2.7M | Other | 1,479,326 | $1.84 | Discretionary |
| Nov 30, 2022 | LUCD | $549.5K | Other | 197,656 | $2.78 | Discretionary |
| Nov 30, 2022 | LUCD | $2.1M | Other | 1,145,086 | $1.84 | Discretionary |
| Oct 18, 2021 | LUCD | $8.0M | Purchase | 571,428 | $14.00 | Discretionary |